Aimei Health Technology Co., Ltd is a leader in healthcare innovation, leveraging artificial intelligence to enhance patient care through advanced diagnostics and treatment solutions. Focused on operational efficiencies and responding to the growing demand for digital health services, the company is strategically well-poised for growth in a rapidly evolving market. Aimei’s commitment to next-generation product development aimed at improving patient outcomes positions it as an appealing investment opportunity, particularly for institutional investors looking to capitalize on the transformative changes within the health technology sector.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.22% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -30.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $4.40M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting